Advertisement
U.S. Markets closed

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
0.0100-0.0050 (-33.33%)
At close: 09:35AM EDT
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
587.094
1,380
2,715
2,593
Cost of Revenue
152.43
103.559
42.779
0
Gross Profit
434.664
1,276
2,672
2,593
Operating Expense
3,014
3,774
4,039
3,119
Operating Income
-2,580
-2,498
-1,367
-526.104
Net Non Operating Interest Income Expense
-125.218
-189.3
-441.656
-515.059
Other Income Expense
-564.394
-522.708
-0.482
-4.197
Pretax Income
-3,269
-3,210
-1,810
-1,045
Net Income Common Stockholders
-3,269
-3,210
-1,810
-1,045
Diluted NI Available to Com Stockholders
-3,269
-3,210
-1,810
-1,045
Basic EPS
-0.02
-0.02
-0.01
-0.01
Diluted EPS
-0.02
-0.02
-0.01
-0.01
Basic Average Shares
132,874
132,634
128,850
93,181
Diluted Average Shares
132,874
132,634
128,850
93,181
Total Expenses
3,167
3,878
4,082
3,119
Net Income from Continuing & Discontinued Operation
-3,269
-3,210
-1,810
-1,045
Normalized Income
-2,705
-2,687
-1,809
-1,041
Interest Income
3.959
24.708
13.184
4.534
Interest Expense
129.177
214.008
454.84
519.593
Net Interest Income
-125.218
-189.3
-441.656
-515.059
EBIT
-3,140
-2,996
-1,355
-525.767
EBITDA
-3,001
-2,866
-1,227
-314.801
Reconciled Cost of Revenue
152.429
103.559
42.779
0
Reconciled Depreciation
139.057
129.831
128.109
210.966
Net Income from Continuing Operation Net Minority Interest
-3,269
-3,210
-1,810
-1,045
Total Unusual Items Excluding Goodwill
-564.394
-522.708
-0.482
-4.197
Total Unusual Items
-564.394
-522.708
-0.482
-4.197
Normalized EBITDA
-2,437
-2,343
-1,226
-310.604
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0